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Abstract: 3D printing is attracting considerable interest for its capacity to produce prototypes and
small production runs rapidly. Fused deposit modeling (FDM) was used to produce polyvalent
test plates for investigation of the physical, chemical, and in-vitro biological properties of printed
materials. The polyvalent test plates (PVTPs) are poly-lactic acid cylinders, 14 mm in diameter and
3 mm in height. The polymer ester backbone was surface modified by a series of ramified and linear
oligoamines to increase its hydrophilicity and introduce a positive charge. The chemical modification
was verified by FT-IR spectroscopy, showing the introduction of amide and amine functions, and
contact angle measurements confirmed increased hydrophilicity. Morphology studies (SEM, optical
microscopy) indicated that the modification of PVTP possessed a planar morphology with small pits.
Positron annihilation lifetime spectroscopy demonstrated that the polymeric free volume decreased
on modification. An MTT-based prolonged cytotoxicity test using Caco-2 cells showed that the PVTPs
are non-toxic at the cellular level. The presence of surface oligoamines on the PVTPs reduced biofilm
formation by Candida albicans SC5314 significantly. The results demonstrate that 3D printed objects
may be modified at their surface by a simple amidation reaction, resulting in a reduced propensity
for biofilm colonization and cellular toxicity.
Keywords: fused deposition modeling; polylactic acid; chemical modification; MTT assay; biofilm formation
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1. Introduction
Three-dimensional (3D) printing has become one of the major innovative technologies of
recent years, and has led to a revolution in personalized medication using medical devices [1]
and modified-release products [2]. The first solid dosage form (Spritam) of a medication printed by
3D technology was approved by the FDA in 2015. Nowadays, 3D printing methods may support the
development of personalized medicine and therapy, for example in cardiac and orthopedic surgeries [3].
This innovative technique has also attracted significant attention in dental and plastic surgeries [4].
There are other technologies that are also being used for biomedical applications; for instance, fused
deposition modeling (FDM) or stereolithography (SLA) [5]. Obviously, the first is used to prepare
medical devices for surgical implantation, but is still onerous and highly expensive, whilst the second is
cheap and suitable for prototyping devices both for biomedical analytical usage and clinical prototyping,
such as drug patches [6]. For both FDM and SLA, commercial polymers or pre-polymers are now
widely available, but little or nothing is known about their behavior in terms of bacterial colonization
or biofilm formation, and indeed whether the printing process itself has an effect on the bio-properties
of the post-printed structures remains to be clarified.
The concept of 3D printing in the medical field is aimed at designing anatomically correct
prototypes using different imaging techniques, such as MRI, CT, and so forth, in which these pictures
are transformed into file formats for 3D printers [7]. The possibility of producing individualized
implants and oral drug formulations holds potential for a variety of different medical purposes.
The use of 3D printing in the chemical sciences has expanded rapidly because different synthesis
processes can be automatically controlled by, for instance, robot technics [8]. Glatzel et al. reported that
a robotic setup may produce 3D printed antibacterial assays, which may promote new opportunities
in the development of laboratory practice [9]. PLA-based implants are widely used due to their
advantageous biodegradability and favorable cytocompatibility properties [10]. They also have good
thermal plasticity and suitable mechanical properties [11]. Scaffold modifications/functionalizations
have a great impact on the morphology and cytocompatibility of medical devices or 3D printed
medicines. Side chain modifications may result in different surface properties [12]. Similarly, the use of
surface absorption of polymers may allow modulation of the chemical and biological properties of 3D
printed scaffolds, as in the very recent paper of Thire et al. on the use of polydopamine absorption
onto 3D printed PLA scaffolds [13].
In a slightly earlier article, surface modification and the anti-microbial properties of the obtained
systems were demonstrated. The previously utilized methods provided access to coated surfaces,
however such systems can be expected to wear over time, which may limit their utility. Direct chemical
modification of the polymers forming 3D printed objects would seem to be of interest, as the actual
surface of the object is changed and not coated [14].
Of the available methods to characterize printed and modified PLA objects, FT-IR will definitively
show the presence of new chemical functions, but intensities of the IR bands may be weak in the case
of surface changes. Contact angle measurements will provide information on the hydrophilicity and
hydrophobicity of the surface, and when correlated with FT-IR allow rapid characterization of surface
chemical modifications. Scanning electron microscopy is an appropriate method for characterization
of porosity and pore size of the surface of implants. Values of positron lifetimes and the corresponding
intensities measured by positron annihilation lifetime spectroscopy may be connected with the size
and the structural defects of implants [15].
To reach the general market with 3D printed implants, these devices must meet all standards
and regulations defined by different authorities [16]. Biocompatibility investigation is a compulsory
test of implantable devices. The ISO 10993-5 standard determines the parameters of the required
cytotoxicity test. The main requirement is the time of contact duration: In the case of limited exposure
the duration time is less than 24 h, and for prolonged exposure 1–30 days of investigation is required.
Contact periods of longer than 30 days is regulated as requiring long-term studies [17]. Caco-2 cells
are mainly used as a monolayer, rather than individual cells, however several assays are performed
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prior to reaching complete integrity, such as the end point or noninvasive cell viability assays (MTT
assay, LDH test, real-time cell electronic sensing assay (RT-CES), etc.) [18]. MTT assay is a broadly
used, rapid colorimetric method to measure the in-vitro cytotoxicity of certain compounds on cell
lines or primary cells. It is usually performed in 96-well plates, thus is a high throughput method,
which excludes cell counting. For decades it was considered as evident that MTT is transformed in
the mitochondria, however in the last few years, doubts have arisen regarding the mitochondrial
localization of the formazan formation [19].
Microbial biofilm formation could be a risk factor of implanted devices, potentially resulting
in unpredictable complications [20]. These microbial biofilm formations may contribute to causing
an inflammatory response and result in subsequent operations, such as dental operations. The ability of
Candida albicans to form biofilms on medical devices could be a key property that enhances its ability to
cause disease in humans [21]. Here, the use of chemical modification may allow inhibition of microbial
biofilm formation, or may enhance such surface colonization. Interestingly, both growth inhibition and
enhancement can be of considerable use to the researcher. A key point in such a modification is the
presence of reactive ester groups in many of the polymers used in 3D printing, thus polylactic acid
(PLA) and polyethylene terephthalate (PET) are based on polymers with ester backbones, whereas
poly(methyl methacrylate) (PMMA) has ester side chain functions.
Many studies have been published on 3D printed implants and dosage forms, however,
the connections between the chemical structures, structural parameters, and cytocompatibility results
have not been well characterized yet. The objectives of our study were to find connections between the
abovementioned parameters in case of chemically modified PLA based 3D printed polyvalent test
plates platforms, or PVTPs. Various amines were used for the post fabrication chemistry to form active
amide functionalities along the surface of 3D printed PVTP structures.
The structural parameters of the samples were evaluated using Fourier transform infrared (FTIR)
spectroscopy, contact angle measurements, scanning electron microscopy (SEM), surface roughness
measurement, and positron annihilation lifetime spectrometry (PALS). A cytotoxicity test based on
an MTT assay on Caco-2 cells and investigation of biofilm formation with Candida albicans were
performed to certify the cytocompatibility of the PVTPs. The work is a first step towards chemical
functionalization of FDM and SLA 3D printed objects and also the study of the cytocompatibility
of generic structures, and shows that simple structures can be produced rapidly and cheaply by 3D
printing for use in biological experiments.
2. Materials and Methods
General: All chemicals were purchased from Sigma-Aldrich, Saint Quentin Fallavier, France and
used without further purification. Deionized water was obtained using a Millipore (Merck Millipore
Direct-Q 5 UV, Millipore SAS, Molsheim, France. 3D printer filaments were purchased from MakerShop
Le Mans, France and stored under dry, dark conditions at room temperature.
2.1. Implant Manufacturing and Side Chain Modification
2.1.1. 3D Printing Technique
The PVTPs were obtained using ColorFabb PLA Naturel filament of 2.85 mm [22]. PLA-PVTPs
were printed using either a Lulzbot Taz 5 or a Lulzbot Mini 3D printer (Aleph Objects Inc., London
UK). The print conditions are summarized in Table 1, below.
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Table 1. Printing characteristics for the plates and plate arrays used in the current work.
Printer Lulzbot Mini Lulzbot Taz 5
Filament Type PLA PLA
Source Maker Shop France Maker Shop France
Filament Diameter; mm 2.85 2.85
Extruder Nozzle Diameter; µm 350 350
Infill Percentage 100 100
Extrusion Temperature (◦C) 215 215
Bed Temperature (◦C) 60 60
Layer Thickness µm 50 75
Print Speed mm/s 50 50
The PVTPs were designed using the Inventor program. The PVTP size was 14 mm diameter
and 3 mm thickness. Batches of 25 were printed on the Lulzbot Mini and 50 on the Lulzbot Taz 3D
printer. As with all FDM printing, initially adhesion happens to the print bed surface then to the
previously printed layers, hence the importance of using the correct bed temperature for each source
of filament [23].
2.1.2. PLA PVTP Modification
The amidation reagents used were ethylene diamine (ED), triethylenetetramine (TET), N-methyl-
1,3-propanediamine (NMePrN bis(aminopropyl)amine (BAPA), 2,2′ (ethylenedioxy)diethylamine
(NPEGN), and tris(2-aminoethyl) amine (Tris). A total of 1000 mL 1 M solution of each amidation
reagent was prepared in deionized water. No coupling reagents were added, as prior work using
adenosine monophosphate had shown clean functionalization under the above conditions [24].
The PVTPs were placed in an in-house reactor, in this case a glass beaker, and 100 mL of the
reactant solution was added. The use of beakers allows objects of dimensions up to 70 mm diameter
and 50 mm height to be modified using low volatility reagents in closed aqueous conditions. The tops
were closed and the system agitated on a rocking incubator for 24 h at 20 ◦C. The PVTPs were then
isolated in a glass funnel and washed five times with 500 mL of deionized water. Finally, the implants
were dried in air, under dust free conditions. The PVTPs were kept in air-tight containers prior to
use [25].
2.2. Material Structure Characterisation
2.2.1. FT Infra-Red Spectroscopy
Fourier transform infrared (FTIR) spectra of the PLA derivatives were recorded at room
temperature by using an IRAffinity-1S FTIR spectrometer (SHIMADZU, Noisiel, France in the
wave number range of 600–4000 cm−1. For these measurements, the samples were directly put on the
attenuated total reflectance (ATR)-FTIR module (Miracle 10) and spectra recorder in the transmittance
(%) mode [26].
2.2.2. Contact Angle Measurement
Contact angle measurements were performed on a Kruss goniometer using DSA3 software (Lyon;
France). A total of 10 µL of deionized water was deposited on the surface of the PVTP, and the droplet
shape was imaged. The contact angle was determined using the internal Kruss software. Measurements
were carried out a minimum of ten times for each PVTP, and the results were the average of the
measurements [27].
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2.2.3. Scanning Electron Microscopy
SEM images were taken with a field emission-scanning electron microscope FE-SEM S-5000
(Hitachi Ltd., Tokio, Japan. Before SEM observation, 4 nm of palladium was deposited by atomic layer
deposition on the treated surfaces, and they were put under vacuum overnight [28].
2.2.4. Surface Roughness Measurement
The PVTPs were imaged using a VHX 6000 optical microscope (Keyence, Jonage, France, and the
images were treated with the internal software to generate line profiles [29].
2.2.5. Positron Annihilation Lifetime Spectrometry
For positron lifetime measurements, a positron source made of carrier-free 22NaCl was used,
for which the activity was around 106 Bq. The active material was sealed between two very thin
Kapton® foils. The source was put between two pieces of implant. Lifetime spectra were measured
with a fast–fast coincidence system based on BaF2/XP2020Q detectors and Ortec® electronics. Three
parallel spectra were measured from each sample. The spectra were evaluated by the RESOLUTION
computer code. Three lifetime components were found in all samples, and the longest component was
identified as positronium triplet state (o-Ps) lifetime [30].
2.3. Cytotoxicity Experiments
2.3.1. Cytotoxicity PLA-Based PVTPs Sterilization
PLA-based PVTPs were immersed in 70% (v/v) ethanol in a laminar air flow (LAF) cabinet for
12 h, and were taken into sterile mull paper individually for drying [31].
2.3.2. Cell Culture
The colon adenocarcinoma (Caco-2) cell line was received from the European Collection of
Cell Cultures (ECACC, Salisbury, United Kingdom, catalogue No.86010202). Caco-2 cell line is
a well-established cell culture in our laboratory. As it can be seen in the article of Nemes et al. the
cell culture is used in based on the same protocol. We state that the Caco-2 cell line provenance is
from ECACC. Cells were seeded in plastic cell culture flasks (Thermo Fisher Scientific Inc., Budapest,
Hungary in DMEM medium supplemented with 3.7 g/L NaHCO3, 10% (v/v) heat-inactivated fetal
bovine serum (FBS), 1% (v/v) non-essential amino acids solution, 1% (v/v) l-glutamine, 100 IU/mL
penicillin, and 100 µg/mL streptomycin at 37 ◦C in an atmosphere of 5% CO2. For the cytotoxic
experiment, cells between 20–40 in passage number were used. The culture media was replaced with
fresh media every three or four days [32].
2.3.3. MTT Cell Viability Test
Cells were seeded on flat bottom 96-well tissue culture plates at a density of 104 or 3 × 104 cells/well.
After sterilization of the test samples separately, they were put in sterile centrifuge tubes and immersed
in 2 mL of the DMEM medium. The samples were stored in a cell incubator at 37 ◦C. The test was
performed on the 4th, 8th, and 12th day, while the samples were stored under the same conditions.
The first step of the MTT assay was to remove the culture media from the cells, then the cells were
treated with 200 µL of the test sample solution and incubated for 30 min. After the incubation time,
the samples were removed and the cells were washed with 200 µL PBS solution/well. Then, the cells
were incubated with 0.5 mg/mL MTT dye. Finally, the formazan crystals were dissolved in acidic
isopropanol (isopropanol: 1.0 N hydrochloric acid = 25:1). The absorbance was measured at 570 nm
against a 690 nm reference with a FLUOstar OPTIMA Microplate Reader (BMG LABTECH, Offenburg,
Germany). Cell viability was expressed as the percentage of the untreated control [33].
Pharmaceutics 2019, 11, 277 6 of 23
2.3.4. Biofilm Formation
In brief, aliquots of 500 µL of standardized SC5314 cell suspension (1 × 106 cells/mL) in Roswell
Park Memorial Institute (RPMI) 1640 medium (Sigma Laboratories Ltd., Budapest, Hungary) were
added into flat bottom 12-well tissue culture plates containing implants (diameter of 1.6 cm), and
incubated at 37 ◦C for 24 h [34]. Afterwards, the samples were taken into a new 12-well plate and
incubated with 0.1% crystal violet solution for 10 min, and the bounded crystal violet was dissolved
with 30% acetic acid. The dissolved solution was taken into a flat bottom 96-well tissue culture plate,
and absorbance was measured at 540 nm in an Anthos HTII spectrophotometer (Anthos, Salzburg,
Austria) [35].
2.4. Statistical Analysis
Data were analyzed using GraphPad Prism (version 7.0; GraphPad Software Inc., La Jolla, CA,
USA) and presented as means ± standard deviations (S.D) of triplicates. Comparison of the groups
was performed by a one-way ANOVA in STATISTICA software version 13. 2. (Statsoft, Tulsa, OKUSA)
at a confidence level of 95%; results were regarded as significant at p < 0.05. All experiments were
carried out in triplicate and repeated at least three times.
3. Results
3.1. Implant Manufacturing and Side Chain Modification
In our experiments, PLA filaments were pre-formed with a localized heating cylinder so the
filaments were melted. Then, the filament was 3D printed at 215 ◦C through a 0.4 mm stainless steel
nozzle, using a layer height of 50 µm or 75 µm. The infill used was 100%, ensuring that porosity arises
from the small spaces between the extruded filaments and any cavities between individual polymer
molecules in the extruded filament. An infill of 100% also ensures high mechanical strength and that
the reactant solution does not enter the printed PVTP and break down inter-layer cohesion. These 3D
printed PLA polymer PVTPs of 14 mm diameter and 3 mm height provided the base for chemical
modification, as shown in Figure 1.
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PLA PVTPs were chemically modified using different amines as side chains. This is unique to our
study, because these 3D printed PLA PVTPs containing amine side chains have not been previously
achieved. The concept of our modifications is based on the work of Haddad et al. [25]. The chemical
reaction used in the surface modification is given in Figure 2A, and the structures of the modified
PVTPs are presented in Figure 2B. PLA as a base polymer has advantageous mechanical properties
and thermoplastic properties [36]. Due to these favorable attributes, it has been widely used in FDM
based 3D printing processes.
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PLA-Tris a ramified di-amine head group.
easurement with a digital icro eter before and after treat ent sho ed an is tropic ecrease
in dia eter and height of 50 µm, showing that 25 µm etching occurs at each surface.
3.2. Material Structure Characterization
3.2.1. FT-IR Characterization of Chemical Modifications
The FT-IR spectra of PLA unmodified and PLA-ED are given in Figure 3, and FT-IR spectra for
all modified PVTPs are given in Appendix A, Figures A1–A7. As expected, the spectrum of PLA
is characterized by a weak C–H stretch band at 3000 cm−1 and a very strong C=O ester stretch at
1750 cm−1. For PLA-ED, additional C=O amide bands are observed at 1550 cm−1 and 1650 cm−1,
and the presence of an amide stretch can only come from the formation of a covalent bond between
the PLA polymer and the ethylene diamine. This is further confirmed by the presence of an N–H
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amide stretch band at 3300 cm−1. As expected from the fact that only surface modification is occurring,
the intensities are much lower than that of the ester C=O band.
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Figure 3. FT-IR spectra of PVTPs of PLA and -ED. The ster C=O band is highlighted by a blue
oval, the amide C=O bands by red circles, and the a ide NH band by a green oval. From the presence
of only the ester C=O stretch in PLA and the presence of both C=O amide and NH amide bands in the
PLA-ED spectra, it is clear that the amide functionalization reaction has occurred, as was previously
observed by time of flight secondary ion mass spectrometry (TOF-SIMS) for the surface modification of
poly-ethylene-terephthalate (PET) by adenosine mono-phosphate (AMP) under the same conditions as
in the current study [24].
3.2.2. Contact Angle Measurement
The contact angle values obtained are given in Figure 4. The contact angle measurement results
can be sorted based on a decreasing volume: PLA PVTP without water wash = PLA PVTP with water
wash > PLA-MeNprN > PLA-ED > PLA-NPEGN > PLA-BAPA > PLA-Tris > PLA-TET. The contact
angle values of our PVTPs were between 26.5 ± 3.0◦ and 69 ± 0.1◦, showing that all the PVTPs are
hydrophilic and that the chemical modification by introduction of polar oligo-amine functions results
in increasing hydrophilicity. As expected, the unmodified PVTPs show the highest contact angles.
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Figure 4. Contact angle values for the various PLA and chemically modified PVTPs. Data are expressed
as means ± SD. Experiments were performed in triplicate, n = 3. Contact angle (◦) values can be
sorted in a decreasing order: PLA PVTP without water wash (69 ± 0.1◦) = PLA PVTP with water wash
(69 ± 0.1◦) > PLA-MeNprN (45 ± 1.3◦) > PLA-ED (41 ± 0.3◦) > PLA-NPEGN (40 ± .1◦) > P -BAPA
(39 ± 0.5◦) > PLA-Tris (30 ± 1.2◦) > PLA-TET (26.5 ± 3.0◦). The PLA PVTP with and without water wash
have statistically significant differences in the contact angle values in comparison with the modified
PLA based samples. PLA-TET and PLA-Tris modifications have statistically significantly lower results
in comparison with the other modified PLA based samples. Error bars represent SD; *, **, and ***
indicate statistically significant differences at p < 0.05, p < 0.01, and p < 0.001, respectively. In general,
surfaces with contact angles of less than 90◦ are considered hemato-compatible.
3.2.3. Scanning Electron Microscopy
The surface of the PLA PVTP and its modifications were tested using a scanning electron
microscope. In our study, both the untreated surface and the deionized water washed surfaces had
the general aspect of a stepped surface, with some small deviation from planarity for the untreated
surface. After washing the surface appeared smoother, correlating with the change in the contact
angle. For the six treated surfaces shown in Figure 5 below (C:PLA-BAPA, D:PLA-ED, G:PLA-Tris, and
H:PLA-NPEGN), all appeared flattened with respect to the initial surface, however all showed a large
number of indentations. PLA-Tris showed ca 1 µm pore diameters. In the case of the TET modified
surface, the overall aspect was close to that of the untreated printed surface, and small indentations
were visible with diameters of ca 100–200 nm. Finally, in the case of the MeNprN modified surface,
etching appeared to have occurred and the surface was separated into iceberg-like systems overlying
a flat surface. This confirms that the surface of the 3D printed PLA PVTPs had been modified, which
confirms the formation of separated plates on the printed surface.
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3.2.4. Optical Microscopy Roughness Measurement
In Figure 6, line sections for PVTPs of unmodified PLA, PLA-Ed, and PLA-NPEGN are given, and
other modifications of line sections can be seen in Appendix B, Figures A8–A10. These were obtained
using a Keyence VHX 6000 optical microscope. Using the internal image processing program, Rz values
of 29 µm for PLA, 3 µm for PLA-ED, and 6 µm for PLA-NPEGN were observed. The values of the PLA
results from the presence of a void of about 20 µm between two extruded polymer filaments, and small
depressions at 400 µm intervals arising from other filaments, were less than 5 µm in depth. The surfaces
of modified PVTPs were generally quite flat with small pits and protrusions present in the modified
samples, which was in agreement with the morphology observed using SEM. No systematically repeated
depressions at 400 µm distances were observed. This was in agreement with the observation that 25 µm
was etched from the PVTP during modification.
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Figure 6. Line sections through printed PVTPs. (A) PLA unmodified 1768 µm length, (B) PLA-ED
4082 µ length, and (C) PLA-NPEGN 4082 µ . Rz values of 29 µ for PLA, 3 µ for PLA-ED, and
6 µ for PLA- PEG are observed.
3.2.5. sitr i ilati ifeti e S ectr etr
i re 7 ill strates t e a era e iscrete o-Ps lifeti e values of various samples. e i er
lifeti e l es i ic te i er free l e les et ee t e l eric c i s, ls resi l
s ce et ee fil e ts. he res lts s e t t t e ifie l eric ses ( t r
NPEGN) were of similar o-Ps lifetimes, thus were free volume holes, while the PLA PVTP represented
significantly higher o-Ps lifetimes. Based on our results, after the modification, PLA-ED and PLA-Tris
contained the most free volume in their structures. PLA-MeNprN had the least free volume in its
structure. The latter could be explained by the fact that through modification, the amines could be built
into the polymeric chains, resulting in smaller free volumes between chains and especially between
polymer molecules in the filaments.
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The results are expressed as the percentage of negative or untreated control (Co−). As a positive 
control (Co+) Triton-X 100 (10% w/v) solubilizing agent was used, which resulted in significant 
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lifetime represents higher free volume holes in the structure of the PLA based PVTPs. Values are presented as
means ± SD. Experiments were performed in triplicate, n = 3. PLA PVTP has statistically significantly different
o-PS lifetime values compared to the odified PLA based samples. In comparison, there is not a statistically
significant different between the modified samples. BAPA = polylactic acid-bis(3-aminopropyl)amine;
ED = olylactic acid-ethylenediamine; TET = polylactic acid-triethylenetetramine; MeNprN = polylactic
acid-N-methyl-1,3-propanediamine; Tris = polylactic acid-tris(2-aminoethyl) amine; and NPEGN = polylactic
acid- 2,2′-(Et le edioxy)diethylamine. Error bar represents SD; **** indicate statistically sig ificant differences
at p < 0.0001.
3.3. Cytocompatibility Experiments
3.3.1. MTT Cell Viability Test
A prolong d cell viability test was utilized in our work to gain information about the cytocompatibility
of our PLA PVTPs. The samples were incubated in the cell culture medium for four, eight, and 12 days,
and the Caco-2 cells were treated by this medium [37,38]. This method differs from the original MTT
assay because the inhibitory concentration (IC50) was not measured, but the cell viability was calculated
in comparison with a negative (DMME medium). In the works of Kinnari and Chessa et al., Caco-2 cell
lines were the gold standard for the cytotoxicity examinations of orthopedic and breast implants [39,40].
Caco-2 cell lines are a model of the intestinal barrier, because numerous attributes are the same as in the
mature enterocyte.
The results are expressed as the percentage of negative or untreated control (Co−). As a positive
control (Co+) Triton-X 100 (10% w/v) solubilizing agent was used, which resulted in significant
differences from the other examined samples. We compared cytotoxic values and found none of the
samples decreased significantly in cell viability compared to the untreated control (Figure 8.) Based on
our MTT assay, PLA-TET cytotoxicity did not decrease under 100% in comparison with the negative
control. PLA-ED, PLA-BAPA, PLA-Tris, and PLA-NPEGN cell viability values were higher than 90% in
the case of prolonged exposure. Based on the ISO 10993-5:2009(E) standard, if the relative cell viability
is higher than 70% in comparison with the control group (100%), the materials can be considered
non-cytotoxic [41]. According to this regulation, all our PLA PVTPs qualified as cytocompatible.
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Figure 8. Prolonged cytotoxicity effects of the PLA based chemically modified PVTPs on CaCo-2 cells
determined by an MTT cell viability test on the 4th, 8th, and 12th days. Cell viability was expressed as
the percentage of untreated control in the case of PLA-based chemically modified PVTPs. The positive
control was Triton X 100 (10% w/v), which has significantly different cell viability results compared to the
Co− and the examined samples. Data are means of three independent experiments ± S.D. We compared
cytotoxic values and found none of the samples decreased significantly in cell viability compared to the
untreated control. Error bars represent SD; *, **, and **** indicate statistically significant differences at
p < 0.05, p < 0.01, and p < 0.001, respectively.
3.3.2. Biofilm Formation
Our experiments were based on the fact that the formed biofilm can be visualized with a crystal
violet (CV) stain, and the absorbance of the dye can be measured. The measured absorbance values
were in correlation with the amount of biofilm in the implants [34,42]. All of the results of biofilm
formation were under a 0.24 absorbance value. PLA PVTP and BAPA modification result in significantly
higher absorbance results than other modifications. MeNprN has higher absorbance results than 0.05,
but TET, Tris, NPEGN, and ED have lower absorbance results than 0.05. In comparison with the
other PVTPs, ED resulted in the smallest absorbance value. (Figure 9). According to the classification
from Marcos-Zambrano et al., low biofilm forming ability occurs with absorbance values under 0.44,
moderate biofilm forming ability occurs between absorbance values of 0.44–1.17, and high absorbance
forming ability occurs with absorbance values above 1.17. Based on this classification, all of our
implants showed low biofilm forming ability [43]. There are some significant differences among the
chemically modified PLA PVTPs because PLA-ED resulted in the lowest biofilm formation, however
PLA-BAPA and PLA PVTP represented the highest biofilm formation.
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4. Discussion
Nowadays, 3D printing technologies for medical purposes are mainly focusing on bioprinting,
dental applications, orthopedic applications, and development of modified release oral drug delivery
systems [2]. In our study, morphological characterization and in-vitro anti-fungal and cytocompatibility
tests of chemically modified PLA-based 3D printed PVTPs are presented. In our research, surface
modification of PLA polymer using oligoamines introduced better anti-infective properties to the
polymer without altering its other properties, however in the paper by Tappa et al., addition of
anti-infective agents was associated with a decrease in the mechanical properties of PLA, even though
it retained its anti-infective properties [44].
Polyvalent test plates were designed for investigation of the physical, chemical, and in-vitro
biological properties of FDM printed materials, thus the term polyvalent in this article refers to the use
of a single structure for testing of a wide range of properties. The advantage of such a PVTP was the
exclusion of effects due to differing geometries, and enabling of the direct comparison between test
results. A polyvalent can be used in many situations—chemistry, physics, mechanics, biology, and cell
growth, and even biofilm formation.
The reason the printed PVTPs were chemically modified was to increase their favorable surface
properties and biocompatibilities. These chemical modifications were verified by FT-IR spectroscopy,
showing introduction of amide and amine functions. The FT-IR data was upgraded, highlighting the
bands corresponding to the ester C=O, amide C=O, and N-H stretches. The intensities of the amide
C=O and N–H are relatively weak as they are surface bonds. Other methods are able to show amide
formation, but none are applicable to surface modification. For example, 13C NMR would not detect C
at less than 0.1% [45]. Other methods would not show the formation of covalent bonds.
There is clear evidence for the influence of surface topographical and wetting characteristics on
macromolecular and cellular levels at implant interfaces [46]. The polymer ester backbone was surface
modified by a series of ramified and linear oligoamines to increase the hydrophilicity of the PVTP
surfaces and introduce positive charge. These hydrophilic surface modifications were certified by
contact angle measurement, which is crucial based on work by Song et al. because wettability of
PVTPs may be affected by chemical modification [47]. However, as ethylene diamine is a small and
highly water soluble molecule, it would be expected to be washed off the surface. This is not the case,
as the contact angle remains constant after washing vigorously. The surface wettability of biomaterials
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determines the biological events at the biomaterial/host interface [46]. Wettability is modulated by
surface chemistry, as was shown in our work and in the articles of Nasrin et al. and Mi et al., because
a large range of solid characterization methods can be used for the qualification of different 3D printed
polymers in these articles [28,48]. There is also evidence regarding the pH dependence of the contact
angle, but the method is as yet not fully proved [49].
The roughness of our PLA based PVTPs was determined by scanning electron microscopy. However,
the result of surface scanning depends on many parameters (i.e., the applied filters, the evaluation
areas, etc.). The assessment of micron, submicron, and nano-roughness of different implant surfaces is
inevitable. Nevertheless, there are only a few standardized methods for the correct determination of
implant surfaces [46], although the prediction of the biological performance of different implants in the
human body is essential.
Positron annihilation spectroscopy (PALS) measures the supramolecular structure of polymeric-based
implants, which can give correct information about the pore sizes and the porosity of the surfaces.
Approximately the upper 100 µm of the surface can be examined with this method, and deviations can
be seen in a nano-dimensional range. This method is based on one of Einstein’s principles, and the
detected o-Ps lifetime values are in correlation with the free volume holes of the samples, which enables the
comparison of the loaded and unloaded delivery bases. The latter could be useful in the characterization of
amorphous solid dispersions or solutions [50].
Comparing the results of PALS and SEM experiments, PLA-ED, PLA-TET, and PLA-Tris all showed
high free volumes and the presence of numerous pits. For PLA-ED and PLA-Tris these were ca 1 µm in
diameter, and for PLA-TET these pits were ca 100–200 nm in diameter. However, for MeNprN, few pits
were present and the free volume was much reduced. Thus, there appeared to be a direct relationship
between the free volume measured by PALS and the presence of large numbers of pits observed by SEM.
PLA showed good biocompatibility results and was biodegradable through hydrolytic
degradation [47]. Our samples were stored in DMEM medium at 37 ◦C until the end of the 12th day,
and these extracts were measured on days four, eight, and 12 on the Caco-2 cells. The incubation
period was 30 min. The cytotoxicity test was harmonized with the ISO 10993-5 standard, but the
incubation period was shorter [41]. There is clear evidence that PLA degrades into lactic acid and
glycolic acid during storage, and different factors (pH, molecular weight, etc.) can influence this
degradation [51]. Many studies have dealt with the degradation of PLA polymers, so the main focus of
our study was not the investigation of PLA degradation but the cytotoxic and biofilm formation effects
of the modified PLA samples stored in DMEM medium, where the samples may degrade. In-vitro
cytotoxicity methods can be the first filter in the assessment of cytocompatibility, because the assay is
sensitive, efficiently adaptable, and well reproducible [52]. MTT assay is a highly efficient screening
test because only the viable cells are able to convert the dye through their mitochondrial enzymes.
Van Tonder et al. revealed that the MTT dye alteration to formazan salt depends on the cells’ metabolic
rate and number of mitochondria [19]. In spite of this limitation of MTT assay, it is still the most
reliable and quickest test for the assessment of cytocompatibility [53]. Ramot et al. revealed that PLA
can provoke an inflammatory reaction through implantation [54]. Silva et al., however, certified our
result because they pointed out that these inflammatory responses, as adverse reactions caused by
PLA samples, are extremely rare [55]. Based on the results of the MTT test our PLA samples proved to
be cytocompatible.
Biofilm formation is also a compulsory element of cytocompatibility examination, based on the
paper by Yang et al. In this research, 3D printed polylactide-co-glycolide and hydroxyapatite PVTPs
were examined [56]. Biofilm formation can be associated with long-term implantation, which can lead
to infections and antimicrobial resistance [34]. During implantation any kind of infection could be
dangerous, because it may result in serious inflammation and the rejection of implants. However,
biofilm formation can alter the structure of PLA and may cause liberation of different APIs in the case
of 3D printed medicine, for example [54]. In our study, biofilm formation was performed with Candida
albicans SC5314 reference isolate, because one of the most common biofilm forming fungi are Candida
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spp. [34] and other species of Candida can cause serious invasive candidiasis, with a mortality rate
of about 45% [57]. Ideally, the measured absorbance is zero, which means that no kind of biofilm
is formed on the implant by the reference isolate. According to the evaluation of biofilm formation,
the chemically modified PLA-PVTPs are biocompatible.
In our paper, we demonstrated the importance of surface characterization and cytocompatibility
investigations of 3D printed PLA- PVTPs and chemically modified PLA-based PVTPs. The amines
as side chains can favorably alter the surface properties, wettability, and biofilm formation of PLA
PVTP. Low biofilm formation ability and favorable cytocompatibility profiles were also presented in
the case of prolonged exposure. There are connections between the type and the other properties of
PLA PVTPs. Overall, the properties of 3D printing materials can be dramatically enhanced by the
modification of base polymers. These implants may ensure a high possibility for the incorporation
of different antimicrobial APIs. According to these results, PLA-ED, PLA-Tris, and PLA-TET PVTPs
can show favorable surface and anti-infective properties. Therefore, these samples were selected for
further in-vivo and/or human studies.
5. Conclusions
To conclude, we have successfully printed 3D PVTPs in runs of up to 50 units, and these have then
been chemically functionalized at the surface by various amine head groups. The surface characterization
confirms the modification. The various types of PVTP show no toxicity. Finally, we note that a suitable
choice of the head group allows Candida albicans biofilm formation to be reduced by a factor of ten.
Based on these in-vitro tests (MTT and biofilm formation tests), it can be concluded that more than one
assay should be used to determine cytotoxicity, so as not to over or underestimate the cytocompatibility
of 3D printed PVTPs. However, cytotoxicity data alone are not necessarily predictive of in-vivo issues,
but alongside other experiments (contact angle, PALS, and SEM results) the in-vivo compatibility data
may be estimated. This work is being extended to other functionalizations, including anionic head
groups and other polymers such as PET or PMMA.
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FT-IR spectra of polyvalent test platforms (PVTP).
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